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Mast cell degranulation is a highly regulated, calcium-
dependent process, which is important for the acute release of
inflammatorymediators during the course ofmanypathological
conditions. We previously found that Synaptotagmin-2, a cal-
cium sensor in neuronal exocytosis, was expressed in amast cell
line. We postulated that this protein may be involved in the
control ofmast cell-regulated exocytosis, andwe generated Syn-
aptotagmin-2 knock-out mice to test our hypothesis. Mast cells
from this mutant animal conferred an abnormally decreased
passive cutaneous anaphylaxis reaction on mast cell-deficient
mice that correlated with a specific defect inmast cell-regulated
exocytosis, leaving constitutive exocytosis and nonexocytic
mast cell effector responses intact. This defect was not second-
ary to abnormalities in the development,maturation,migration,
morphology, synthesis, and storage of inflammatory mediators,
or intracellular calcium transients of themast cells. Unlike neu-
rons, the lack of Synaptotagmin-2 in mast cells was not associ-
ated with increased spontaneous exocytosis.
Mast cells (MCs)2 participate in adaptive and innate immune
responses. Their secreted products play important roles in
immunoglobulin E (IgE)-dependent inflammatory reactions
such as allergic asthma and anaphylaxis (1) and are also
involved in other forms of inflammation such as immune
arthritis (2, 3) and innate immune responses to bacterial infec-
tions (4, 5). Upon activation, MCs exhibit three main secretory
responses: release of granule contents (i.e. degranulation),
secretion of prostaglandins and leukotrienes, and secretion of
cytokines and growth factors (6). The exocytic release of pre-
formed mediators (e.g. histamine and proteases) stored in
secretory granules is immediate and regulated at the step of
fusion between the membrane of the granule and the plasma
membrane. Thus, it is an example of regulated exocytosis, like
neuronal synaptic neurotransmitter release and insulin secre-
tion (7). Another early event is the release of metabolites of
arachidonic acid (e.g. prostaglandin D2 (PGD2) and leukotriene
C4 (LTC4)). These eicosanoids cross the plasma membrane
using transmembrane transporters (8), and their production is
regulated by the activation of their synthetic enzymes (9). A late
response after MC activation is the secretion of cytokines and
growth factors (e.g. tumor necrosis factor- (TNF-) and inter-
leukin-4 (IL-4)). The gap in time of minutes to hours between
stimulation and the secretion of thesemediators is explained by
the fact that regulation is at the transcriptional and post-tran-
scriptional levels, with secretion occurring via constitutive exo-
cytosis (10).
A common intracellular mediator linking the stimulation
event to these three MC responses is calcium (Ca2) that is
released into the cytoplasm from intracellular stores and intro-
duced from the extracellular environment via specialized chan-
nels. Increase in the cytoplasmic concentration of Ca2
([Ca2]i) is required for the activation of phospholipase A2 and
other enzymes in the synthetic pathway of prostaglandins and
leukotrienes, for the expression of cytokines and growth fac-
tors, and for the regulated exocytosis of MC secretory granules
(11).
MC degranulation is a highly regulated process, and, like
other exocytic events, it requires the participation of soluble
NSF (N-ethylmaleimide-sensitive fusion protein) adaptor pro-
tein receptor (SNARE) proteins. These are present both on the
cytoplasmic surfaces of secretory vesicles (v-SNAREs such as
vesicle-associated membrane protein, VAMP) and of the
plasma membrane (target or t-SNAREs such as Syntaxin and
synaptosome-associated protein of 25 kDa, SNAP-25). Cognate
v- and t-SNAREs form a highly stable quadruple -helix com-
plex (core complex) apposing the vesicle and target mem-
branes. According to the “zipper hypothesis” the coiling of this
complex drives the fusion between thesemembranes, opening a
fusion pore and releasing the vesicle contents into the extracel-
lular space (12). This step is Ca2-dependent and is under the
control of multiple proteins such as Synaptotagmin (Syt) (13).
There are at least 15 Syts in mammals, and several of them
mediate Ca2-dependent exocytosis. All Syts have a short
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intravesicularN terminus, a transmembrane domain, a variable
linker region, and two conserved C2 domains (C2A and C2B) at
their C terminus. The binding of Ca2 to the C2 domains alters
their electrostatic surface charge andmediates most of the Ca2-
dependent functions of Syt (13). The C2A domains of Syt1, -2,
and -9 bind Ca2 with low affinity and high cooperativity.
These Syts were first identified in neurons where they control
fast, synchronous, Ca2-dependent synaptic vesicle exocytosis.
Syt1 mediates this form of exocytosis in forebrain neurons (14)
and Syt9 in limbic and striatal neurons (15). Both of them also
mediate rapid exocytosis of dense core granules in adrenal
chromaffin cells. We showed that Syt2 functions as the Ca2
sensor for fast synchronous synaptic vesicle release in hind-
brain neurons and at the neuromuscular junction and that dele-
tion of Syt2 produces a severe neurologic phenotype that
results in death during the third week of postnatal life (16, 17).
These low Ca2 affinity Syts also inhibit spontaneous and slow
asynchronous vesicle exocytosis in the neurons where they are
expressed (14–17). We previously identified Syt2 as the major
Syt isoform expressed in the RBL-2H3 MC line (18). Here we
study the effects of Syt2 deficiency inMC secretion in vivo. We
show that Syt2-null mice contain normal MCs in number and
morphology in their peritoneal cavity and skin and that MCs
can be generated from the bone marrow of these mutant mice.
Although no defects were found in IgE-dependent generation
and secretion of cytokines and eicosanoids, the MCs in our
Syt2-null mice had a marked deficiency in the exocytosis of
their preformed granule mediators.
EXPERIMENTAL PROCEDURES
Animals and Cells—MC-deficient and Syt2 knock-out mice
have been described (17, 19). We produced all experimental
animals and littermate controls by heterozygous crossings of a
Syt2/ line that we backcrossed 13 times into C57BL/6. We
harvested and purified peritoneal MCs as described (4). We
harvested bone marrow from femurs of postnatal day 16 (P16)
mice to generate bone marrow-derived MCs (BMMCs). Cells
were grown in RPMI 1640 (with 1% fetal calf serum, 100 M
Hepes buffer pH 7.3, 1 mM sodium pyruvate, 1 nonessential
amino acids, and 0.1% -mercaptoethanol) supplemented with
mIL-3 5 ng/ml and stem cell factor (SCF) 100 ng/ml for 6weeks.
We followed the viability of BMMCs by Trypan Blue exclusion,
and their maturation and differentiation by flow cytometry
using labeled antibodies against the -subunit of the high affin-
ity receptor for IgE (FcRI; eBioscience) and cKit/CD117 (BD
Pharmingen).
Immunohistochemistry and Immunoblotting—Cytospins of
peritoneal MCs were postfixed with cold acetone, blocked with
3% bovine serum albumin/0.4% Triton X-100, incubated first
with rabbit anti-Syt2 antibody 1:500 (A320; Dr. T. C. Su¨dhof,
Stanford University School of Medicine, Stanford, CA) (17) for
16 h at 4 °C, then with peroxidase-conjugated antirabbit anti-
body (Jackson Immunoresearch) for 2 h at room temperature,
and finally with 3,3-diaminobenzidine (DAB; Vector). We
used the same antibody for the immunoblotting of peritoneal
MC lysates resolved by SDS-PAGE and transferred to nitro-
cellulose membranes. GAPDH (glyceraldehyde-3-phosphate
dehydrogenase), detected with a specific antibody (Abcam),
was used as a loading control.
Microscopy—Weharvested and processed tissues, peritoneal
lavage, and electron microscopy (EM) samples from P16 mice
as described (4). In tissue sections, we stained MC secretory
granules with fluorescein isothiocyanate (FITC)-avidin and
nuclei with Hoechst (Invitrogen-Molecular Probes), and then
counted nucleatedMC profiles (FITC/Hoechst) in random-
ized sections. In ears, we used the autofluorescence of cartilage,
epidermis, and muscle in the red channel to calculate the der-
mis area by subtracting the cartilage andmuscle areas from the
area between the two epidermal edges. We counted peritoneal
MCs using a Neubauer chamber and cytospins (Wright-Gi-
emsa). We obtained EM pictures of BMMCs and peritoneal
MCs using an unbiased random sampling technique.We calcu-
lated the volume fraction and the surface density of the granules
using the point counting method with a cycloid grid, and the
profile area using a point grid (20).
Secretion Assays—For each experiment, we suspended 106
BMMCs in 1 ml of culture medium and sensitized them with
anti-2,4-dinitrophenol (DNP) IgE 5 g/ml for 3 h. After
repeated washes, we stimulated them with 100 ng/ml of DNP-
human serum albumin (DNP-HSA).Wemeasured all products
in supernatants before and after stimulation.We alsomeasured
-hexosaminidase in cell lysates (106 BMMCs treatedwith 1ml
of 0.2% Triton X-100). After stimulation, we measured LTC4
and PGD2 at 30 min, -hexosaminidase and histamine at 1 h,
TNF- at 6 h, and IL-4 at different time points. We used
enzyme-linked immunosorbent assays (ELISA, Oxford Biomed
Res) to measure all products except -hexosaminidase activity,
which was measured by colorimetry using as substrate 4-nitro-
phenyl N-acetyl--D-glucosaminide.
MC Reconstitution and Passive Cutaneous Anaphylaxis
(PCA)—We used BMMCs derived from Syt2/ or Syt2/
P16mice for reconstitution of both ears ofMC-deficient B6.Cg-
KitW-sh/KitW-sh (Wsh/Wsh) mice. After 6 weeks in culture, 105
BMMCs were suspended in 25 l of PBS and injected intrader-
mally into each ear pinna. Six weeks later, we quantified the
MCs in the ears of some animals by histology and then per-
formed the PCA sensitization and challenge on the rest as
described (4).
Intracellular Ca2 Measurements—Peritoneal MCs from
P16mice were sensitized with 3 g/ml of anti-DNP IgE for 2 h,
plated onto coverslips and incubated in 5MFura 2-AM. Intra-
cellular calcium of each individual MC was ratiometrically cal-
culated (21, 22). The fluorescence of an unstimulated MC was
measured for 60 s prior to the addition of DNP-HSA to a final
concentration of 0.5 g/ml.
Electrophysiological Recordings—Whole cell capacitance
measurements of individual peritoneal MCs were made at
room temperature using 5 to 6 M sylgard-coated patch
pipettes (21). The intracellular recording solution both defined
the [Ca2]i and stimulated exocytosis (23–25). It contained
(mM) 135 potassium gluconate, 7 MgCl2, 3 KOH, 2.5 K2EGTA,
7.5Ca-EGTA, 0.2Na-ATP, 0.005 Li4GTPS, and 0.1 bis-Fura 2,
10 HEPES (pH 7.2, 305 mOsm) (23), with a calculated free
[Ca2] of700 nM that was experimentally verified. The exter-
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nal recording solution contained (mM) 140 NaCl, 2.5 KCl, 2
CaCl2, 1MgCl2, 10 glucose, 10HEPES (pH 7.2 and 310mOsm).
RESULTS ANDDISCUSSION
Syt2 Expression inMCs—In previous studies, we showed that
Syt2 is themain Syt isoform expressed in the RBL-2H3MC line
(18). Neurons from Syt2/ mice have severe impairments in
Ca2-dependent-regulated exocytosis (16, 17), sowewondered
if this low Ca2 affinity exocytic Syt may play a similar role in a
non-neuronal cell, such as theMC, inwhich activation does not
depend on Ca2 entry through voltage-gated channels in the
plasma membrane. Our first step was to confirm expression of
Syt2 in normal MCs using cells from our Syt2/mice as neg-
ative controls. Immunoblots of Syt2/ MC lysates showed
intense staining at 80 kDa, whereas Syt2/ MC lysates
showed no immunoreactivity at this mobility (Fig. 1A), and we
observed perigranular immunohistochemical staining for Syt2
only in Syt2/ peritoneal MCs (Fig. 1B). Together, these
results provide evidence of the expression of Syt2 in mature
endogenous MCs.
Syt2 Deficiency Impairs an MC-dependent Allergic Reaction—
PCAmodels the acute phase of an allergic reaction. In PCA, we
measure the localized vasodilation and increased endothelial
permeability induced by products secreted by skin-resident
MCs (26). All animals we used are on a C57BL/6 genetic back-
ground. We initially found a decreased PCA response in
Syt2/mice compared with Syt2/mice (not shown). A flaw
in these pilot experiments was that altered responses of Syt2-
deficient cells other than MCs (e.g. vascular smooth muscle
relaxation and endothelial cell retraction) could also be respon-
sible for the observed difference. To avoid this confounding
factor and to guarantee that only the MCs in our model will be
differentially deficient or sufficient in Syt2, we reconstituted
Syt2-sufficientMC-deficientWsh/Wshmice with BMMCs from
Syt2/ and Syt2/mice. In histological analysis performed 6
weeks after reconstitution, we identified 101  11 and 98  9
(mean  S.E.; n 	 4) MCs per mm2 of dermis at the site of
injection in Wsh/Wsh mice that received Syt2/ and Syt2/
BMMCs, respectively. As shown in Fig. 2, MC-deficient ani-
mals failed to mount a response to the antigen challenge. This
reaction was rescued by intradermic reconstitution with
Syt2/ BMMCs. Reconstitution with Syt2/ BMMCs pro-
vided only a partial (about one-third) rescue compared with
Syt2/ BMMCs. Pharmacologic interventions have deter-
mined that PCA is highly dependent on histamine. Given that
this vasoactive amine is stored in MC secretory granules and
released during degranulation, and that the presence of a Ca2-
binding exocytic Syt defines an exocytic event as regulated, we
postulated that the lack of Syt2 was negatively affecting MC-
regulated exocytosis.
Syt2DeficiencyDoesNotAffectMCNumbers, Differentiation,
Structure, or Storage of Granule Contents—To rule out the pos-
sibility that the defective response to PCA was due to an unex-
pected effect of the absence of Syt2 on some aspect of MC
development, we examinedMC structure and differentiation in
Syt2/mice.We foundnodifference in theMCdensity in skin
(Fig. 3A and Table 1), peritoneal fluid (Fig. 3B and Table 1),
tongue, trachea, stomach, or jejunum (not shown) between
Syt2/ and Syt2/mice. EM images of peritoneal MCs from
animals of both genotypes were indistinguishable (Fig. 3C) and
unbiased stereological analysis to measure the size and surface
complexity of the cells and the number, size, and density of
their granules showed no difference (Table 1). We also did not
find a difference in the rate of differentiation of bone marrow
cells into BMMCs in SCF and IL-3-enriched medium (Table 1)
or in the surface density of immunoreactivity against cKit/
CD117 and FcRI in BMMCs after 6 weeks in culture (Fig.
3D). Morphometric analysis of electron micrographs of
Syt2/ and Syt2/ BMMCs also failed to uncover a differ-
ence (Fig. 3E and Table 1). As part of the secretion assays
described below we found almost identical amounts of total
cellular histamine (Table 1) and-hexosaminidase activity (not
shown) in unstimulated Syt2/ and Syt2/ BMMCs.
Based on these results, we concluded that the lack of Syt2 did
not affect the proliferation, migration, and maturation of MCs,
the morphology of these cells and of their secretory granules,
the expression of receptors important for their maturation and
stimulation, and the storage of preformed inflammatory medi-
ators in their secretory granules. Thus, none of these factors
explained the defective acute allergic cutaneous response
described in Fig. 2.
Syt2 Selectively Controls Regulated Exocytosis in MCs—
Other possibilities thatwe needed to test were that the deficient
PCA response was part of a more extensive defect affecting all
forms of MC secretion and/or the activation of MCs. We stud-
ied the functional consequences of the absence of Syt2 in the
three main MC secretory effector responses: regulated exocy-
FIGURE 1. Syt2 is expressed in mature MCs. Peritoneal MCs purified from
P16 Syt2/ and Syt2/ mice. A, immunoblot of cell lysates with anti-Syt2
antibody (Syt2). GAPDH immunoreactivity was used as a loading control.
B, immunohistochemistry of cytospins using the same antibody (bar, 4 m).
We demonstrated the presence of Syt2 in mature wild type MCs and the
absence of Syt2 in Syt2/MCs. FIGURE 2.Syt2deficiency impairs the response inpassive cutaneous ana-
phylaxis. Ears ofMC-deficientWsh/Wshmice reconstituted intradermallywith
Syt2/ or Syt2/ BMMCs were sensitized with anti-DNP IgE (experimental
ear) or polyclonal IgE (control ear). After intravenous challengewithDNP-HSA
in Evans Blue, the amount of extravasated dye was measured as absorbance
at 610 nm. Nonreconstituted MC-deficient animals failed to respond, and
there was amarked difference betweenmice reconstitutedwith Syt2/ and
Syt2/ BMMCs. (Error bars represent S.E.; n	 9; *, p
 0.01.)
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tosis, constitutive exocytosis, and nonexocytic secretion (6). To
simulate the conditions used in our PCAmodel, we used FcRI
cross-linking to stimulate BMMCs from Syt2/ and Syt2/
mice. After incubating the cells with anti-DNP IgE, we stimu-
lated themby applyingDNP-HSA. Because excess of polyvalent
antigen can interferewith FcRI cross-linking, we used the anti-
gen to cell ratio that induced the maximum secretory response
in our system (106 BMMCs in 1 ml of DNP-HSA at 100 ng/ml,
Fig. 4A). To assess exocytosed secretory granule contents, we
measured the enzymatic activity of -hexosaminidase
(expressed as a fraction of total cellular content; Fig. 4,A and B)
and the amount of histamine (expressed in absolute values, Fig.
4C) in the cell supernatants before and after stimulation. In
both cases we found that Syt2/ cells showed only about a
third of the response found in Syt2/ cells.We next measured
the release of cytokines under transcriptional control and
secreted via constitutive exocytosis, and found no difference in
the total amount released (TNF-, Fig. 5A) or in the time course
of this response (IL-4, Fig. 5B).Wedid not find any difference in
the release of products that do not depend on exocytosis for
their secretion such as PGD2 and LTC4 (Fig. 5, C and D).
The normal secretion of cytokines and lipid mediators,
together with the normal surface expression of FcRI (Fig.
FIGURE 3.Syt2deficiencydoesnot alterMCdevelopment,migration into
tissues, or morphology. Representative images of samples obtained from
P16 Syt2/ and Syt2/mice are shown.An in-depthmorphometric analysis
canbe found inTable1.A, fluorescentmicroscopyof ear sections (bar, 50m).
MCswere labeledwith FITC-avidin (green) and cell nuclei with Hoechst (blue).
Background tissue was visualized as autofluorescence in the red channel.
Syt2/ and Syt2/mice had similar densities of MCs in the dermis of their
ears. B, cytospins of peritoneal lavages stained with Wright-Giemsa (bar, 100
m). Insets depict higher power magnifications of representative MCs (bar, 5
m). Syt2/ and Syt2/mice had similar numbers ofMCswith similar gross
morphology in their peritoneal cavities. C, transmission EMof peritoneal MCs
(bar, 1 m). MCs from Syt2/ and Syt2/mice had similar size and surface
complexity, and similar number, size, and density of electron-dense granules.
D, flow cytometry of BMMCs. After 6 weeks in medium supplemented with
SCFand IL-3, BMMCs from Syt2/and Syt2/micehad the sameproportion
of Kit/FcRI cells (% in brackets), and similar surface expression of both
receptors (gray lines near both axes represent mean  S.D. of fluorescence
intensity). E, transmission EM of BMMCs (bar, 1 m). Syt2/ and Syt2/
BMMCs were indistinguishable.
TABLE 1
Quantitation, morphometry, and cellular contents of studied MCs
Values obtained from four animals of each genotype are expressed asmean S.E.Vv
denotes granule volume fraction, Sv, granule surface density, andA, cell profile area.
Syt2/ Syt2/
Dermal MCsa
106 cells/m2 183 15 182 12
Peritoneal MCsb
% 9.7 1.7 9.3 1.1
106 cells/liter 180 13 174 16
Peritoneal MCsc
Vv 0.25 0.02 0.26 0.02
Sv, 106 m1 22.89 1.71 21.82 2.85
A, 1012 m2 33.82 2.97 32.76 0.78
BMMCs in cultured
2 weeks, % 17.2 3.1 19.1 3.9
4 weeks, % 89.1 4.4 86.2 5.4
6 weeks, % 97.5 1.2 97.1 1.4
BMMCs (6 w)c
Vv 0.41 0.04 0.39 0.03
Sv, 106 m1 20.77 2.01 20.46 1.14
A, 1012 m2 43.11 2.88 48.58 2.78
BMMCs histaminee
103 g/liter 0.93 0.11 0.97 0.09
a FITC-avidin cells with a Hoechst nuclear profile per area of dermis in random
sections of ear (10 samples/animal).
b Calculated from Neubauer chamber counts and Wright-Giemsa staining of cyto-
spins of peritoneal lavages (3 samples/animal).
c Stereological analysis of randomly acquired EM images from peritoneal MCs and
BMMCs after 6 weeks in culture (10 cell profiles/sample, 4 samples/animal).
d Percent of Kit/FcRI double positive cells in bonemarrow cultures inmedium
enriched with SCF and IL-3 assessed by flow cytometry (1 sample/animal/time
point).
e Total histamine concentration in lysates of 106 BMMCs measured by ELISA
(1 sample/animal).
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3D), point to an intact IgE-dependent stimulation mechanism
inMCs lacking Syt2, and excludes a defect in this pathway as an
explanation for our findings. The presence of an abnormal and
selective defect in degranulation confirms that, like in neurons
and neuroendocrine cells, the presence of a Ca2-binding Syt
defines an exocytic step as a regulated event (7). Our finding
that Syt2 discriminates between the secretory compartment
containing both -hexosaminidase and histamine from that
containing cytokines is very similar to the findings on VAMP-8
in MCs (27). Another study suggested that VAMP-8 may fur-
ther discriminate between subpopulations of granules released
by regulated exocytosis, as it may control the release of sero-
tonin, cathepsin-D, and-hexosaminidase but not of histamine
(28). Because we found a similar defect in the secretion of
-hexosaminidase and histamine (Fig. 4, B andC), we postulate
that there may be only a single secretory granule population
that contains bothmediators or that Syt2 controls the exocyto-
sis of the two granule subpopulations.
In nonexcitable cells, another Syt that regulates exocytic
events is the high affinity Ca2-binding Syt7 (29), an ubiqui-
tously expressed protein that associates with lysosomal com-
partments. Although its function in MCs is not known, it is a
good candidate to explain the residual exocytic response seen in
Syt2/MCs. Similar functional redundancy can explain why
the inhibition of VAMP-7, VAMP-8, and Stx-4 with neutraliz-
ing antibodies does not entirely inhibit the release of histamine
from MCs compared with the complete suppression obtained
with anti-SNAP-23 antibodies (30). Finally, we found no struc-
tural or functional difference between Syt2/ and Syt2/
MCs (not shown), so there is no phenotypic haploinsufficiency,
similar to our findings in synapses and neuromuscular junc-
tions (16, 17), but different to what we have observed in airway
mucous cells (31).
Syt2 Deficiency Does Not Lead to Increased Spontaneous
Degranulation in MCs—In neurons, Syt2 plays a double role: it
is required for the fast synchronized component of the evoked
exocytic release of synaptic vesicles, and it also suppresses the
slow nonsynchronized component of this process and the
spontaneous exocytic events that occur in the absence of stim-
uli (16, 17). As shown in Fig. 4C, we did not find a difference in
the baseline concentration of histamine in the supernatants of
Syt2/ and Syt2/ BMMCs, even when these measurements
were repeated over 24 h (results not shown). Also, as described
in Table 1, the amount of histamine present in cells of both
genotypes was almost identical, so there was no evidence of
depletion of internal stores.
Thus, like in neurons, Syt2 inMCs is required for an effective
regulated exocytic response, but unlike in neurons, its absence
does not produce an increase in spontaneous fusion events
resulting in depletion of stored products. An explanation for
this difference may be the nature of the membrane fusion
machinery in these different cells. Neurotransmission takes
place within milliseconds after an action potential induces
influx of Ca2. In neurons, secretory vesicles are docked at
active zones with VAMP-2, SNAP-25, and Syntaxin-1 forming
a partially coiled SNARE complex. The cytoplasmic protein
complexin “clamps” the complex in this state and prevents
complete coiling andmembrane fusion. At low [Ca2]i Syt pro-
FIGURE 4. Syt2 deficiency affects MC-regulated exocytosis. BMMCs from
Syt2/ and Syt2/ mice were incubated with anti-DNP IgE and then
exposed to DNP-HSA. Secreted products were measured in supernatants
before and 1 h after stimulation. Total -hexosaminidase enzymatic activity
was also measured in cell lysates. A, secretion of -hexosaminidase with dif-
ferent doses of DNP-HSA. Values are expressed as the difference in enzymatic
activity in supernatants between stimulated and unstimulated cells in per-
cent of total activity in cell lysates. Themaximal response and greatest differ-
encewere found at 100 ng/ml DNP-HSA (n	 3). This concentrationwas used
in all subsequent experiments.B, secretionof-hexosaminidase at 100ng/ml
DNP-HSA (n 	 8). C, histamine in supernatants before (open bars) and after
(black bars) challenge (n 	 5). Release of products stored in MC secretory
granules and secreted via regulated exocytosiswas significantly decreased in
Syt2/ BMMCs. (Error bars represent S.E.; *, p
 0.01.)
FIGURE 5. Syt2 deficiency does not affect other MC secretorymechanisms.
Secreted products weremeasured in supernatants of BMMCs from Syt2/ and
Syt2/ mice incubated with anti-DNP IgE before and at different time points
after addition of DNP-HSA. A, TNF- before (open bars) and after (6 h, black bars)
challenge (n 	 5; color legend applies also to C and D). B, time course of IL-4
secretion (n	 3per timepoint).C, PGD2 andD, LTC4 30min after challenge (n	
4 for both). Secretion dependent on constitutive exocytosis or independent of
exocytosis was not affected in Syt2/ BMMCs. (Error bars represent S.E.)
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motes this action of complexin, but as [Ca2]i rises, Syt dis-
places complexin and actively promotes the “zippering” of the
quadruple helix, driving membrane fusion (32). In MCs, regu-
lated exocytosis takes place over minutes and depends on dif-
ferent complexins, v- and t-SNAREs. Perhaps because there is
no need for an immediate coupling of Ca2 entry with exocy-
tosis, the “clamping” effect of Syt2 is not required in MCs, and
that may be a consequence of a different interaction with com-
plexin or with the SNARE complex. An alternative explanation
is that another Syt isoform plays this negative role in MC
exocytosis.
Syt2 Deficiency Does Not Alter the Stimulated Rise of [Ca2]i
inMCs—Inneurons andmuscle cells, some voltage-gatedCa2
channels physically interact with the exocytic proteins Syn-
taxin, SNAP-25, and Syt. These interactions help localize syn-
aptic vesicles to the active zone and alter the permeability to
Ca2 of these channels (33). Furthermore, some Syt channel
complexes are the target of autoantibodies in Lambert-Eaton
myastenic syndrome (34). Even though there is no reported
physical or functional interaction between a Syt and the inositol
trisphosphate receptor, STIM (stromal interaction molecule),
or components of theCa2 release activatedCa2 channel such
as Orai1/CRACM1, it was important to confirm that the defec-
tive exocytic response we found in Syt2/MCswas not due to
an impairment of store-operated Ca2 entry in this nonexcit-
able cell (35).
In purified peritoneal MCs passively sensitized with specific
IgE,we foundnodifference in the increase of [Ca2]i ([Ca2]i)
after challenge by exposure to the cognate antigen (Fig. 6,A and
B). Thus, it is a deficiency in a Ca2 sensor, and not in upstream
Ca2 signaling that explains the degranulation defect in
Syt2/MCs.
Syt2 Deficiency Does Not Impair Secretory Granule Exocytic
Competence in MCs—Another possibility we explored was to
determine whether the effects of lack of Syt2 inMCs were indi-
rect, affecting exocytosis by altering the competence of the core
exocytic machinery. For example, the deletion of VAMP-2 (36)
or SNAP-25 (37) produces a defect in neurotransmitter release
that cannot be overcome by any stimulus because a core com-
ponent of the neuronal exocytic machinery is absent.
Single peritoneal MCs from Syt2/ and Syt2/mice were
strongly stimulated by intracellular dialysis with GTPS and a
persistent high [Ca2]i (25), while measuring plasma mem-
brane capacitance (Cm). We found no difference in plasma
membrane capacitance gain (Cm), demonstrating that the
total amount of granule membrane incorporated into the
plasma membrane via exocytosis was the same, and therefore
that the membrane fusion machinery was intact (Fig. 6, C and
D). Similar to our findings, application of an intervention that
induces neuronal exocytosis via a mechanism independent of
Syts (hypertonic sucrose) to neurons deficient in Syt1 (14), Syt2
(16), or Syt9 (15) elicited similar levels of vesicle fusion when
compared with wild-type controls.
Summary—We found that Syt2 controls exclusively regu-
lated exocytosis in MCs in vitro and in vivo and not consti-
tutive exocytosis or nonexocytic secretion. We also found
that this Ca2 sensor has no “clamping” activity on sponta-
neous exocytosis in this nonexcitable cell. Although the
defect in Syt2-deficient mice is profound, it is not absolute,
and it would be interesting to explore if another Syt such as
Syt7 could explain this residual exocytic activity. We also
found that the PCA reaction is highly dependent on MC-
regulated exocytosis, suggesting that it may be possible to
control the acute phase of the allergic response by manipu-
lating this exocytic step.
FIGURE 6. Syt2 deficiency does not affect [Ca2]i transients or MC exo-
cytic competence.A, representative [Ca2]i traces of isolatedperitonealMCs
incubatedwith anti-DNP IgE and stimulatedby additionofDNP-HSA (arrows).
Gray lines represent themean baseline andmaximal [Ca2]i used to calculate
[Ca2]i. B, average [Ca
2]i showed no difference between the two geno-
types (n	 9). C, representative Cm traces (upper panels) measured in perito-
neal MCs dialyzed with 5M GTPS via the patch pipette. The [Ca2]i in both
cells was buffered to 700 nM (lower panels). D, average Cm demonstrated
that degranulation can be induced in Syt2/ MCs under these conditions
(n	 8; error bars represent S.E.).
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